Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Clinical Reviews in Allergy & Immunology|January 20, 2016
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative GroupLorenzo Cavagna, Laura Nuño, Carlo Alberto Scirè, et al.
Medicina (Kaunas, Lithuania)|August 26, 2023
Long-Term Retention Rate of Tofacitinib in Rheumatoid Arthritis: An Italian Multicenter Retrospective Cohort StudyMarino Paroli, Andrea Becciolini, Elena Bravi, et al.
Journal of Clinical Medicine|July 13, 2024
Influence of Safety Warnings on the Prescribing Attitude of JAK Inhibitors for Rheumatoid Arthritis in ItalyMarino Paroli, Andrea Becciolini, Alberto Lo Gullo, et al.
Minerva Medica|October 8, 2024
Multicenter observational study on the efficacy of selective Janus Kinase-1 inhibitor upatacitinib in rheumatoid arthritisAlberto Lo Gullo, Simone Parisi, Andrea Becciolini, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 28, 2024
Clinical Characteristics of Anti-Synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome ProjectSara Faghihi-Kashani, Akira Yoshida, Francisca Bozan, et al.
Therapeutic Advances in Musculoskeletal Disease|May 11, 2026
Drug retention of TNF versus IL-23 inhibitors in psoriatic arthritis: a multicenter real-life cohort studySimone Parisi, Andrea Becciolini, Bernardo D'Onofrio, et al.
Clinical and Experimental Rheumatology|March 15, 2024
Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobankAravinthan Loganathan, Giovanni Zanframundo, Akira Yoshida, et al.
Journal of Psoriasis and Psoriatic Arthritis|May 16, 2025
Ixekizumab Retention Rate and Predictors of Treatment Persistence in Psoriatic Arthritis: Results of an Italian Multicenter StudyCamilla Mazzanti, Marino Paroli, Gianluca Santoboni, et al.
Pageof 4